An in vitro 125IUdR-release assay for measuring the kinetics of cell death.

A radionuclide release assay for measuring the in vitro kinetics of cell death has been developed. CHO cells were labelled for 24 h with 3.0 hBq/ml of [125I] iododeoxyuridine (125IUdR) and the fate of the labelled cells and their progeny was monitored at daily intervals by measuring the rate of 125I release. Prelabelling with 125IUdR did not alter the plating efficiency, the doubling time or the selection of mitotic cells. The rate of 125I release from labelled (but otherwise untreated) CHO cells was approximately equal to 4% day. Treatment with a lethal dose of X-rays (30 Gy), heat (46 degrees C, 1 h), cold (-90 degrees C, 1 h) or the antibiotic Geneticin (300 micrograms/ml, continuously) resulted in the release of greater than 99% the 125I activity associated with the cells. Cell death was rapid after heating or freezing, and delayed after treatment with X-rays or Geneticin. The results illustrate the efficacy of the 125I release assay for measuring the kinetics of cell death in mammalian tissue culture cells.

[1]  J. Friedland,et al.  Radiosensitizing and cytocidal effects of misonidazole: evidence for separate modes of action. , 1987, Radiation research.

[2]  K. Hofer.  Heat potentiation of radiation damage versus radiation potentiation of heat damage. , 1987, Radiation research.

[3]  K. Hofer,et al.  The target for radiation-induced division delay. , 1980, Radiation research.

[4]  W. Dewey,et al.  Hydroxyurea retards the progression of G2 cells. , 1978, Experimental cell research.

[5]  L. Braby,et al.  Division delay after low X-ray doses and treatment with cycloheximide. , 1977, Radiation research.

[6]  E. W. Bradley,et al.  The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. , 1975, Radiation research.

[7]  D. Kern,et al.  Brief Communication: Quantltatlon of Cytotoxic Antitumor Antibody In Vitro: A Microassay With 125I-lododeoxyuridineas a Tumor Cell Label , 1974 .

[8]  R. Seeger,et al.  An analysis of variables affecting the measurement of tumor immunity In vitro with 125I‐iododeoxyuridine‐labelled target cells. Studies of immunity to primary moloney sarcomas , 1974, International journal of cancer.

[9]  K. Hofer,et al.  Ga-citrate and I-iododeoxyuridine as markers for in vivo evaluation of tumor cell metastasis and death. , 1973, Journal of the National Cancer Institute.

[10]  W. Dewey,et al.  Use of the mitotic selection procedure for cell cycle analysis. Comparison between the X-ray and cycloheximide G2 markers. , 1972, Experimental cell research.

[11]  L. Dethlefsen.  Reutilization of 131I-5-iodo-2'-deoxyuridine as compared to 3H-thymidine in mouse duodenum and mammary tumor. , 1970, Journal of the National Cancer Institute.

[12]  W. Prensky,et al.  Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. , 1969, Journal of the National Cancer Institute.

[13]  Mortimer M. Elkind,et al.  The radiobiology of cultured mammalian cells , 1967 .

[14]  S. L. Commerford,et al.  Biological Stability of 5-lodo-2′-deoxyuridine labelled with Iodine-125 after its Incorporation into the Deoxyribonucleic Acid of the Mouse , 1965, Nature.

[15]  D. Gitlin,et al.  DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE. , 1964, Federation proceedings.

[16]  P. Vittorio,et al.  THE USE OF CHROMIUM-51 AS A SENSITIVE QUANTITATIVE CRITERION OF EARLY RADIATION DAMAGE TO RAT THYMOCYTES. , 1964, Canadian journal of biochemistry.

[17]  T. Puck,et al.  ACTION OF X-RAYS ON MAMMALIAN CELLS , 1956, The Journal of experimental medicine.